Ardent Animal Health

Overview
News
Animal Therapeutics?
Product stageSegments
Early
?
Oncology therapeutics, Regenerative therapeutics
?

Ardent Animal Health, formerly known as MediVet Biologics, is a veterinary biotechnology company based near Lexington, Kentucky. Since its inception in 2016, the company has focused on developing affordable and innovative treatments for canine cancer and joint diseases in companion and equine animals. Ardent's core mission is to assist veterinary partners in providing advanced care and making a positive impact on pet health.

Ardent offers several innovative treatments for pets. ActiStem Therapy is an in-clinic adipose regenerative stem cell therapy kit, a significant advancement in animal regenerative medicine. It provides an economic solution for pets suffering from osteoarthritis, hip dysplasia, ligament and cartilage injuries, and various mobility ailments. Additionally, Ardent offers PureVet PRP (Platelet-Rich Plasma), a same-day treatment that harnesses the healing abilities of the patient's blood platelets.

For canine cancer, Ardent has introduced K9-ACV, a cutting-edge cancer vaccine service generated from a canine patient's cancerous tumor. K9-ACV is designed to stimulate the immune system to attack the cancer cells. In October 2022, Ardent licensed a novel checkpoint inhibitor cancer treatment for dogs, developed by researchers from the University of Minnesota College of Medicine, to strengthen its cancer treatment pipeline.

In October 2023, Ardent Animal Health signed a licensing agreement with Athersys, Inc., granting Ardent exclusive rights to Athersys' Multipotent Adult Progenitor Cell (MAPC) technology for non-human mammal applications in the US. This agreement aims to advance stem cell therapy for joint diseases and other areas of unmet need in animal health.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
220 Bellaire Drive Nicholasville, KY, US 40356 Nicholasville KY USA
Founded year:
2016
Employees:
51-100
IPO status:
Private
Total funding:
-
Last Funding:
-
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.